The latest PR news from the Holmes Report.
Opinion and commentary from the Holmes Report.
The Holmes Report's Echo Chamber PR show lifts the lid on key stories and trends.
Latest video interviews and campaigns from the Holmes Report.
Long-form journalism that analyzes the issues, challenges and opportunities facing the business and practice of PR.
Industry-leading analysis of the PR stories that matter.
Up close and personal with leaders from the marketing and PR worlds.
Keeping up with the latest thinking on PR industry expansion.
Coverage of the Cannes Lions from the Holmes Report in association with ICCO.
Coverage of the World Economic Forum in Davos.
The Holmes Report's annual analysis of the top reputation crises to rock the corporate sector.
The Holmes Report's annual forecast of trends that will impact the PR world in the year ahead.
Diversity & inclusion trends, views and analysis from the Holmes Report.
Creative work, trends and views from the global public relations industry.
Dedicated to exploring the new frontiers of PR as it dives deeper into social media, content and analytics.
Our coverage of key technology PR trends and challenges from around the world of digital communications.
From brand marketing to conscious consumerism, coverage of key marketing and PR trends worldwide.
Coverage of global corporate reputation and communications news and trends, from the leading online corporate PR news website The Holmes Report. Subscribe today!
The Holmes Report's coverage, analysis and news around the rapidly-shifting area of employee engagement and internal communications.
Sports PR news, diversity & inclusion trends, views and analysis from the Holmes Report. Subscribe today for the very latest in the world of sports communications.
The Holmes Report's definitive global benchmark of global PR agency size and growth, new for 2018.
The Holmes Report's annual selections for PR Agencies of the Year, across all of the world's major markets.
The world's 100 most powerful corporate communicators.
The Holmes Report profiles marketing and communications innovators from across North America, EMEA and Asia-Pac.
The most creatively awarded PR campaigns and agencies in the world.
In-depth annual research into the PR industry's efforts to raise creative standards.
The key global benchmark of PR agency rankings, industry size and global trends.
The world's biggest PR awards programme, dedicated to benchmarking the best PR work from across the globe.
The biggest PR conference of the year, a high-level forum designed for senior practitioners to address the critical issues that matter most.
Exploring the innovation and disruption that is redefining influence and engagement.
Unrivalled insight into the world's best PR agencies, across specialist and geographic categories.
Bringing together in-house comms leaders with PR firms to discuss critical global issues.
The PR industry’s most comprehensive listing of firms from every region and specialty
Find the latest global PR and communications jobs from the Holmes Report. From internships to account executives or directors. See all our PR jobs here.
Content from the Holmes Report's premium partners.
The Holmes Report's editorial series published in collaboration with partners.
Healthcare public relations is seen as a recent growth driver among many of the major multinational agencies operating in the region, but there is nothing new about FleishmanHillard’s emphasis on the sector, which has been a key component of its regional business since it expanded into Asia more than 20 years ago. Its capabilities have expanded from pharmaceutical marketing to include market access, regulatory and legislative issues, clinical trial work, and technical medical communications across the full lifecycle of products from drugs to devices.
The firm has strong healthcare teams in Bangkok, Beijing, Hong Kong, Jakarta, Kuala Lumpur, Manila, Mumbai, New Delhi, Seoul, Shanghai, Singapore, Sydney, Tokyo, and also collaborates with other Omnicom-owned healthcare-focused agencies to deliver an even broader array of services across even more markets. More and more of that work involves engaging directly with consumers, as they look for information themselves rather than blindly following “doctor’s orders,” leading to increased demand for digital and social content.
Fleishman’s healthcare business was once again the star performer among its regional practice groups in 2018, up 24% for a client roster that includes Amgen, Reckitt Benckiser, GSK, Johnson & Johnson and Pfizer’s oncology portfolio. And that growth was underscored by SABRE-nominated work for J&J, which addressed diversity and inclusion in India. — AS
The healthcare sector should be fertile territory for public relations firms in the Asia-Pacific region. The issues that help healthcare specialists flourish in other markets—a regulated environment that precludes much advertising, the benefits of an educated and informed patient base, a myriad of issues from safety to pricing—are amplified in Asia by the opportunity presented by an expanding middle class and an ageing population. In Korea, there are more than 6.8 million people over the age of 65, and about half live in poverty. And yet, the market is home to relatively few sophisticated healthcare specialists.
Enzaim Health was founded in 2003 as The Communication Enzaim under the leadership of CEO Dingseok Kim and has expanded to offer expertise in public relations, marketing, public education and publications to a client list that includes both corporate and government clients: MSD Korea, Pfizer Korea, Gilead Korea, Omron Korea, Nestle Korea, Eisai Korea, Astellas Korea, Korea CDC, Korea Medical Association, the Ministry of Health & Welfare.
The firm is mission-driven, balancing “people, nature and animal” through four core values: health for all, professionalism, creativity, and ownership. That has helped to attract an impressive team, including PR practice leader Song-hee Kim, whose background spans journalism and in-house communications roles. The seven-person PR team has expertise in corporate branding, corporate social responsibility, health education campaigns, and consumer health (food, cosmetics and lifestyle products and services). — PH
In the five years since its launch, SPAG has already established itself as an industry game changer in the Asia-Pacific market as a cross between a public affairs and healthcare shop with three distinct brands: SPAG Asia, D Yellow Elephant and Giga Health (which was acquired in 2016).
Since its 2013 launch, the firm has grown consistently by at least 80% year-over-year while still keeping headcount low with the philosophy that one right individual is worth more than 10 others. SPAG serves an impressive client roster that includes Novartis, Johnson & Johnson, Abbott, Pfizer, Baxter and Boston Scientific among others. The firm has never lost a client.
In 2017, SPAG laid the groundwork for continued success by developing a four-year growth plan that includes the creation of a holding company (Strategic Partners Group) for its brands; rolling out new offerings such as a food & nutrition practice; and taking its business to Europe through partnerships with life science companies targeting the Asia-Pacific region. All of which are in sync with SPAG’s overarching strategy of growing its business through expanding its capabilities rather than its client roster; SPAG has doubled, and even tripled, revenue from existing clients by expanding its breadth of services. The firm is banking on big payoffs, with projections calling for its fee income to rise from its current $4m to $12-15m within four years. — AaS
Accounting for around nine percent of its regional revenue, Weber Shandwick still believes its healthcare practice is underweight in the region, despite rebounding into 2018 growth following a flat 2017. Key clients include Pfizer, Abbott, Johnson&Johnson, Ocean Spray and Merck, and there was also new business over the past 12 months from Convatec, Gilead, Grail, IFPMA, Novartis, Pierre Fabre and Roche.
In particular, 2017 saw Weber Shandwick expand its healthcare professionals offering via the hire of scientific director Cathy Chow, enabling the firm to offer more specialised educational counsel for brands across the region. And the firm’s public awareness campaign work remains among the best in the region, exemplified by SABRE nominated efforts for MSD India, Lamisil and Gardasil, all campaigns that also integrate a strong digital component.
Indeed, that digital focus is likely to help Weber Shandwick’s healthcare practice shed its underweight status. Already, the firm has won lead agency work for 3 GSK in China, along with assignments for Novartis and Manuka Honey. — AS
We feel that the views of the reader are as important as the views of the writer. Please contact us at [email protected]Signup For Our Newsletter Media Kits/Editorial Calendar Jobs Postings Sitemap
© The Holmes Report 2020